Last year EvidentIQ released alongside Novo Nordisk, Neo4j, and Microsoft, a new solution for managing clinical data standards and study design specifications, the OpenStudyBuilder.
In the world of pharmaceuticals, metadata management is crucial for the success of clinical trials. Managing metadata can be a complex task, with several challenges involved, such as data inconsistencies, bottlenecks between systems and processes, and manual work. To simplify this process, EvidentIQ offers a Manage Service Model for OpenStudyBuilder users to support them with their specific requirements.
EvidentIQ provides a range of Managed Services for OpenStudyBuilder that can help pharmaceutical companies streamline their metadata management process. These services include Migration, Consulting, and Customization.
EvidentIQ’s team of experts migrate the Metadata Repository to OpenStudyBuilder. Once fully integrated, they guarantee End-to-End consistency, ensuring that all data is accurately transferred and maintained. They also provide consulting services on all issues related to OpenStudyBuilder. They have been specialists in CDISC standards since 2003 and can help with any questions or concerns. At the same time, EvidentIQ customizes OpenStudyBuilder for client’s specific trials, ensuring that it meets all trials requirements.
With their team of experts and their extensive experience in CDISC standards, EvidentIQ can help customize the OpenStudyBuilder to the specific business needs and ensure that all data is consistent, accurate, and reliable.
EvidentIQ is a next generation technology-amplified data science group championing new standards in value creation and innovation driven relevance for customers. The EvidentIQ offering brings a pioneering end to end eClinical solution that meets increasing customer demand across clinical operations and clinical data management needs with a suite of applications within a single integrated cloud platform. By combining its platform with a broad data science service portfolio such as patient recruitment, patient engagement media and a host of RWE late phase solutions EvidentIQ significantly helps customers optimize HTA submissions, pricing and reimbursement needs.
EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.
EvidentIQ Group GmbH
Rathausmarkt 5
20095 Hamburg
Telefon: +49 (89) 4522775000
Telefax: +49 (89) 4522775900
https://evidentiq.com
Business Development
Telefon: 089452277500
